• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD THORAFLEX HYBRID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD THORAFLEX HYBRID Back to Search Results
Model Number THORAFLEX HYBRID
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Date 08/29/2023
Event Type  Injury  
Event Description
Patient had type b disecssion with bental in the past the observation of the condition of the patient after fet by using thoraflex is the fever that cannot stop.The doctor described that after surgery patient got a fever and he monitored to cut the fever with antibiotic but it is still happening and he still investing the reason.
 
Manufacturer Narrative
Manufacturers narrative; section h6; clinical code: 1930 - unspecified infection reported.Impact code: 4641 - unexpected medical intervention , patient has been given antibiotics.4624 - unexpected surgical intervention , graft was explanted.4648 - insufficient information - further information has been requested from the site.Medical device problem 2993 - adverse event without identified device or use problem,- further information has been requested from the site.Component code 4755 part/component/sub-assembly term not applicable: type of investigation 4109 historical data analysis: no negative trend in the number of complaints received has been identified.4110 trend analysis: a 5-year review of similar complaints (thoraflex hybrid / medical event ( fever) ) gave an occurrence rate of 0.008% (complaints v sales).3331 analysis of production records: sterilization records review and a full batch review was performed which showed no issues with product.Review of the ifu mentions that infection is a potential adverse event.4114 device not returned: device is no longer available to be returned to tag for investigation.
 
Manufacturer Narrative
Manufacturers narrative: section h6: clinical code: 1930 - unspecified infection reported.Impact code: 4641 - unexpected medical intervention , patient has been given antibiotics.4624 - unexpected surgical intervention , graft was explanted.4648 - insufficient information - no further information provided from site.Due to this the complaint will be closed.2993 - adverse event without identified device or use problem,-no further information provided from site.Due to this the complaint will be closed.Component code: 4755 part/component/sub-assembly term not applicable: type of investigation: 4109 historical data analysis: no negative trend in the number of complaints received has been identified.4110 trend analysis: (b)(4) (complaints v sales).3331 analysis of production records: sterilization records review and a full batch review was performed which showed no issues with product.Review of the ifu mentions that infection is a potential adverse event.4114 device not returned: device is no longer available to be returned to tag for investigation.Investigation conclusion : 3221- no findings available: no further information provided from site.Due to this the complaint will be closed.Investigation conclusion: 4315- cause not established: no further information provided from site.Due to this the complaint will be closed.
 
Event Description
Patient had type b disecssion with bental in the past the observation of the condition of the patient after fet by using thoraflex is the fever that cannot stop.The doctor described that after surgery patient got a fever and he monitored to cut the fever with antibiotic but it is still happening and he still investing the reason.Full batch review was performed which showed no issues with the finished product or raw materials.No further information provided from complainant, due to this the complaint will be closed this report is being submitted as final for mfg report #9612515-2023-00021 to provide event closure information for(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THORAFLEX HYBRID
Type of Device
THORAFLEX HYBRID
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, PA49R R
UK  PA49RR
Manufacturer (Section G)
VASCUTEK LTD.
newmains avenue
inchinnan business park
glasgow,, renfrewshire PA4 9 RR,
UK   PA4 9RR,
Manufacturer Contact
jason whittle
newmains avenue
inchinnan
glasgow, PA49R-R
UK   PA49RR
MDR Report Key17903392
MDR Text Key325250256
Report Number9612515-2023-00021
Device Sequence Number1
Product Code QSK
UDI-Device Identifier00537881031736
UDI-Public0537881031736
Combination Product (y/n)N
Reporter Country CodeVM
PMA/PMN Number
P21006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 11/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTHORAFLEX HYBRID
Device Catalogue NumberTHP2628X100B
Device Lot Number25239302
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/07/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age27 YR
Patient SexMale
-
-